Cromos Pharma, where the patients are

Drug Sponsors

MGC Diagnostics to acquire Medisoft

Friday, March 21, 2014 11:08 AM

MGC Diagnostics, a global medical technologies company, has entered into a letter of intent to acquire Medisoft of Sorinnes, Belgium. MGC Diagnostics would acquire all the outstanding shares of Medisoft stock. Medisoft, a privately held independent manufacturer of Cardio-Respiratory diagnostics products, had 2013 revenues of approximately $6.6 million.

More... »

CRF Health eCOA webinar series

Report: Patients expect sponsors to help them manage their health

Friday, March 21, 2014 11:03 AM

Accenture, a global management consulting, technology services and outsourcing company, has released a survey of 2,000 patients in the U.S. taking long-term, short-term or lifestyle medications, which found that the vast majority (76%) believe pharmaceutical companies should provide services that complement the products they provide. 

More... »

NIH, three others earn AAHRPP accreditation

Thursday, March 20, 2014 02:46 PM

The nonprofit Association for the Accreditation of Human Research Protection Programs has accredited four more organizations: the U.S. National Institutes of Health; King Fahad Specialist Hospital-Dammam, Saudi Arabia; Taipei Medical University Hospital, Taiwan; and St. Jude Children’s Research Hospital, Memphis, Tenn.

More... »

StemTech to open Florida facility, hire 90

Wednesday, March 19, 2014 12:55 PM

Stemtech International, a stem cell technology company, will move its headquarters from San Clemente, Calif., to Pembroke Pines, Fla., creating 90 jobs.

More... »

Teva, NIHR form health research collaboration

Wednesday, March 19, 2014 12:50 PM

Israeli pharmaceutical company Teva will invest $20 million into U.K. clinical trials and $1 million into U.K. dementia research. Teva said it will benefit from the NIHR's translational research infrastructure and its ability to efficiently set up and deliver world-leading health research studies.

More... »

SillaJen completes Jennerex acquisition

Monday, March 17, 2014 01:44 PM

SillaJen, a privately held biotherapeutics company focused on the development of targeted oncolytic immunotherapy products for cancer, has completed the acquisition of San Francisco-based Jennerex. Privately held Jennerex is a clinical-stage, biotherapeutics company developing best-in-class targeted oncolytic immunotherapies.

More... »

Vectura Group acquires Activaero

Monday, March 17, 2014 01:38 PM

Vectura, a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases, has acquired Activaero, a private German pharmaceutical company focused on the development of products for the treatment of respiratory diseases, for $179.6 million, to be funded through a combination of existing cash and equity.

More... »

AstraZeneca sells Alderley Park site in Cheshire, U.K.

Wednesday, March 12, 2014 01:41 PM

AstraZeneca has sold its Alderley Park site in Cheshire, U.K., to Manchester Science Parks(MSP), a Greater Manchester-based public-private partnership and science park operator.

More... »

Intrexon completes acquisition of MediStem

Monday, March 10, 2014 11:50 AM

Intrexon, a provider of synthetic biology, has completed the acquisition of San Diego-based Medistem, a pioneer in the development of Endometrial Regenerative Cells (ERCs), universal donor adult-derived stem cells with properties uniquely suited for therapeutic use with Intrexon's existing suite of synthetic biology technologies.

More... »

Stratus Media Group acquires Paloma Pharmaceuticals and VasculoMedics

Monday, March 10, 2014 11:48 AM

Stratus Media Group (SMDI) has announced the acquisition, through merger, of two biotechnology companies, Paloma Pharmaceuticals, a developer of a non-steroidal, synthetic, small molecule drug library, and VasculoMedics, a platform epigenetic company that develops orally available small molecular inhibitors of zinc finger transcription factors.

More... »

CenterWatch Data Library



Browse by:


April 21

Healthcare IPOs soar in first quarter

Survey compares 'push/pull' tactics in patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs